The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
Source link : https://www.nytimes.com/2025/02/04/health/fda-mdma-psychedelic-therapy-psymposia.html
Author : Andrew Jacobs and Rachel Nuwer
Publish date : 2025-02-04 15:26:00
Copyright for syndicated content belongs to the linked Source.
